With the analysis among 7,085 patents, we discovered top 433 key players by total patent application. Vertex Pharmaceuticals, Inc., IRM LLC, Novartis AG are dominant in this area. They take 32.63% of the total patent filing.
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1,464
CITY OF HAMILTON, Bermuda
Patent: 456
Basel-Stadt, Switzerland
Patent: 392
Colorado, United States
Patent: 273
California, United States
Patent: 207
F. Hoffmann-La Roche Ltd.
New York, United States
Patent: 144
New York, United States
Patent: 130
New Jersey, United States
Patent: 97
With the analysis among 139 patents, we discovered top 12 start-ups by total patent application. HepaRegeniX GmbH, iOmx Therapeutics AG, Institut National de la Santé et de la Recherche Médicale are active in this area.
Baden-Württemberg, Germany
Patent: 38
Bayern, Germany
Patent: 22
Institut National de la Santé et de la Recherche Médicale
Shanghai KeChow Pharmaceuticals Co., Ltd.
Shanghai Shi, China
Patent: 12
Sumitomo Dainippon Pharma Oncology, Inc.
California, United States
Patent: 9
Bretagne, France
Patent: 5
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 5
Shanghai Drug Farm Biological Technology Co., Ltd.
Shanghai Shi, China
Patent: 3
With the analysis among related 944 patents applied in the last 5 years. We discover 215 most active companies in this area. The fast-growing Vertex Pharmaceuticals, Inc., HepaRegeniX GmbH, Shenzhen Chipscreen Biosciences Co., Ltd. take 11.65% of patent filing during this period.
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 42
Baden-Württemberg, Germany
Patent: 38
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 30
Minnesota, United States
Patent: 30
Beijing Tide Pharmaceutical Co., Ltd.
Beijing Shi, China
Patent: 26
Bayern, Germany
Patent: 22
Shengke Pharmaceutical (Jiangsu) Co., Ltd.
Korea Institute of Science & Technology
With the analysis among related 944 patents in last 5 years, we discover 129 new entrants. HepaRegeniX GmbH, Nanocopoeia, Inc., iOmx Therapeutics AG are the most active new entrants in this area.
Baden-Württemberg, Germany
Patent: 38
Minnesota, United States
Patent: 30
Bayern, Germany
Patent: 22
Shengke Pharmaceutical (Jiangsu) Co., Ltd.
Kymera Therapeutics, Inc.
Massachusetts, United States
Patent: 13
Chengdu Chipscreen Pharmaceutical Ltd.
Sichuan Sheng, China
Patent: 13
Dizal Pharmaceutical Co., Ltd
Jiangsu Sheng, China
Patent: 13
California, United States
Patent: 11
Baden-Württemberg, Germany
Patent: 10
With the analysis among 578 patents, we discovered top 94 universities and scientific research institutions by total patent application. The Scripps Research Institute, Korea Institute of Science & Technology, Institute Of Cancer Research are dominant in this area. They take 30.45% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 96
Korea Institute of Science & Technology
Institute Of Cancer Research
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 23
Regents of the University of Colorado
Colorado, United States
Patent: 13
Guangdong Sheng, China
Patent: 10
Baden-Württemberg, Germany
Patent: 10
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 10
New Jersey, United States
Patent: 8
Tartumaa, Estonia
Patent: 7